Plasma YKL-40 is elevated, defined as higher than the age-adjusted 95th percentile of plasma YKL-40 in healthy subjects, in 45% of patients with metastatic melanoma and in 13% of patients with stage I melanoma [73,74], Figure 4. The gene discussed is CHI3L1; the disease is metastatic melanoma.